PLIN1 anticorps (N-Term)
Aperçu rapide pour PLIN1 anticorps (N-Term) (ABIN629870)
Antigène
Voir toutes PLIN1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Perilipin antibody was raised against the N terminal of PLIN
-
Purification
- Purified
-
Immunogène
- Perilipin antibody was raised using the N terminal of PLIN corresponding to a region with amino acids STQFTAANELACRGLDHLEEKIPALQYPPEKIASELKDTISTRLRSARNS
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Perilipin Blocking Peptide, (ABIN5615312), is also available for use as a blocking control in assays to test for specificity of this Perilipin antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PLIN antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
-
: "Low Neonatal Plasma n-6/n-3 PUFA Ratios Regulate Offspring Adipogenic Potential and Condition Adult Obesity Resistance." dans: Diabetes, Vol. 67, Issue 4, pp. 651-661, (2018) (PubMed).
-
: "Low Neonatal Plasma n-6/n-3 PUFA Ratios Regulate Offspring Adipogenic Potential and Condition Adult Obesity Resistance." dans: Diabetes, Vol. 67, Issue 4, pp. 651-661, (2018) (PubMed).
-
- PLIN1 (Perilipin 1 (PLIN1))
-
Autre désignation
- Perilipin
-
Sujet
- PLIN coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis.
-
Poids moléculaire
- 57 kDa (MW of target protein)
-
Pathways
- Lipid Metabolism
Antigène
-